Skip to Content
Sharon M Weber, MD, FACS

Contact Dr. Weber

E-mail:
webers@surgery.wisc.edu

Phone:
(608) 262-2025

Mail:
600 HIGHLAND AVE
BX7375 CLINICAL SCIENCE CNTR
MADISON, WI 53792-3284

Fax:
(608) 252-0913

Sharon M Weber, MD, FACS

Professor and Chief, Division of Surgical Oncology
Vice Chair of Academic Affairs, Divisions of General Surgery
Medical Director of Surgical Oncology, UW Carbone Cancer Center

Education

  • M.D, University of Wisconsin Medical School, Madison, WI, 1993
  • Residency in General Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, 1993-1999
  • Research Fellowship in Tumor Immunotherapy, University of Wisconsin Medical School, Madison, WI, 1996-1997
  • Surgical Oncology Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 1999-2001
  • Hepatobiliary Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 2000-2001

Dr. Sharon Weber trained at Memorial Sloan-Kettering Cancer Center, with dual fellowships in surgical oncology and hepatobiliary. She specializes in benign and malignant disorders of the liver, pancreas and bile duct, in addition to gastric cancer, melanoma and sarcoma.

Clinical Specialties

Dr. Weber is actively involved in minimally invasive approaches to cancer treatment, including both laparoscopic pancreas and liver surgery. She has been invited as a speaker/moderator at many national meetings, including the American College of Surgeons, the American Hepatopancreaticobiliary Association, Society of Surgical Oncology, and Society of University Surgeons.

Dr. Weber provides a wide range of services including Bile Duct Resection, Caudate Resection, Cryoablation, Cyst Fenestration (Unroof Liver Cyst), Cytoreductive Surgery with HIPEC, Frey Procedure, Gastrectomy - Partial or Total, Hemihepatectomy (Hepatectomy), Laparoscopic Liver Resection, Laparoscopic Pancreatectomy, Liver Resection, Liver Tumor Ablations, Melanoma Completion Lymph Node Dissection (Axillary and Groin), Melanoma Sentinel Lymph Node Biopsy, Melanoma Wide Local Excision and Skin Closure, Obstructed Pancreatic Duct Drainage (Peustow Procedure), Pancreatic Head Resection, Pancreaticoduodenectomy, Pancreatic Pseudocysts Drainage, Pancreatic Resections, (show all).

Research Interests

Dr. Weber conducts translational research at the UW Carbone Cancer Center evaluating novel tumor selective agents which may be promising for imaging and/or treating tumors. She also conducts clinical research evaluating prognosticators of outcome in patients with liver, bile duct, and liver tumors.

Active Clinical Trials
  • A Phase II Study of Preoperative Gemcitabine and Erlotinib Plus Pancreatectomy and Postoperative Gemcitabine and Erlotinib for Patients With Operable Pancreatic Adenocarcinoma
    Principal Investigator(s): Sharon M Weber, MD, FACS
    Status: Active, not recruiting
    [ClinicalTrials.gov: NCT00733746]
    More Information

Recent Publications
  • Human pancreatic stellate cells modulate 3D collagen alignment to promote the migration of pancreatic ductal adenocarcinoma cells.
    Drifka CR, Loeffler AG, Esquibel CR, Weber SM, Eliceiri KW, Kao WJ
    Biomed Microdevices 2016 Dec; 18(6):105.
    [PubMed ID: 27819128]
    More Information
  • A Novel Pathology-Based Preoperative Risk Score to Predict Locoregional Residual and Distant Disease and Survival for Incidental Gallbladder Cancer: A 10-Institution Study from the U.S. Extrahepatic Biliary Malignancy Consortium.
    Ethun CG, Postlewait LM, Le N, Pawlik TM, Buettner S, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Jin LX, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Merchant N, Cardona K, Maithel SK
    Ann. Surg. Oncol. 2016 Nov 3.
    [PubMed ID: 27812827]
    More Information
  • Role of Operative Complexity Variables in Risk Adjustment for Patients With Cancer.
    Liu JB, Weber SM, Berian JR, Chen S, Cohen ME, Ko CY, Bilimoria KY
    JAMA Surg 2016 Nov 1; 151(11):1084-1086.
    [PubMed ID: 27486963]
    More Information
  • Association of Optimal Time Interval to Re-resection for Incidental Gallbladder Cancer With Overall Survival: A Multi-Institution Analysis From the US Extrahepatic Biliary Malignancy Consortium.
    Ethun CG, Postlewait LM, Le N, Pawlik TM, Buettner S, Poultsides G, Tran T, Idrees K, Isom CA, Fields RC, Jin LX, Weber SM, Salem A, Martin RC, Scoggins C, Shen P, Mogal HD, Schmidt C, Beal E, Hatzaras I, Shenoy R, Kooby DA, Maithel SK
    JAMA Surg 2016 Oct 26.
    [PubMed ID: 27784058]
    More Information
  • Minimally Invasive Resection of Adrenocortical Carcinoma: a Multi-Institutional Study of 201 Patients.
    Lee CW, Salem AI, Schneider DF, Leverson GE, Tran TB, Poultsides GA, Postlewait LM, Maithel SK, Wang TS, Hatzaras I, Shenoy R, Phay JE, Shirley L, Fields RC, Jin LX, Pawlik TM, Prescott JD, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Weber SM
    J. Gastrointest. Surg. 2016 Oct 21.
    [PubMed ID: 27770290]
    More Information

webmaster@surgery.wisc.edu Copyright © 2016 The Board of Regents of the University of Wisconsin System